Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

US FDA declines to approve Merck and Eisai’s liver cancer combo therapy

expresspharmaJuly 10, 2020

Tag: Eisai , Merck , Liver cancer , Lenvima , Keytruda

PharmaSources Customer Service